Menstrual blood‑derived stromal cells modulate functional properties of mouse and human macrophages by Martínez Aguilar, Rocío et al.
1
Vol.:(0123456789)
Scientific Reports |        (2020) 10:21389  | https://doi.org/10.1038/s41598-020-78423-x
www.nature.com/scientificreports
Menstrual blood‑derived stromal 
cells modulate functional 
properties of mouse and human 
macrophages
Rocío Martínez‑Aguilar1, Salvador Romero‑Pinedo1, M. José Ruiz‑Magaña1, 
Enrique G. Olivares2,3, Carmen Ruiz‑Ruiz1,2,4* & Ana C. Abadía‑Molina1,2,4*
Menstrual blood‑derived stromal cells (MenSCs) are emerging as a strong candidate for cell‑based 
therapies due to their immunomodulatory properties. However, their direct impact on innate immune 
populations remains elusive. Since macrophages play a key role in the onset and development of 
inflammation, understanding MenSCs implication in the functional properties of these cells is required 
to refine their clinical effects during the treatment of inflammatory disorders. In this study, we 
assessed the effects that MenSCs had on the recruitment of macrophages and other innate immune 
cells in two mouse models of acute inflammation, a thioglycollate (TGC)‑elicited peritonitis model 
and a monobacterial sepsis model. We found that, in the TGC model, MenSCs injection reduced the 
percentage of macrophages recruited to the peritoneum and promoted the generation of peritoneal 
immune cell aggregates. In the sepsis model, MenSCs exacerbated infection by diminishing the 
recruitment of macrophages and neutrophils to the site of infection and inducing defective bacterial 
clearance. Additional in vitro studies confirmed that co‑culture with MenSCs impaired macrophage 
bactericidal properties, affecting bacterial killing and the production of reactive oxygen intermediates. 
Our findings suggest that MenSCs modulate the macrophage population and that this modulation 
must be taken into consideration when it comes to future clinical applications.
Menstrual blood-derived stromal cells (MenSCs) are considered a type of mesenchymal stromal cells (MSCs), 
originally located in the endometrium, that can be isolated from menstrual fluid. MenSCs share characteristics 
with other MSCs such as being plastic-adherent cells, expressing typical mesenchymal stromal cell surface mark-
ers, being capable of differentiating into mesodermal cell lineages in vitro and displaying a low immunogenic 
 profile1,2, which makes them a good candidate for clinical use in cell-based therapies.
Since their first characterisation by Meng et al.1 in 2007, MenSCs have aroused great interest as an alterna-
tive source of MSCs other than bone  marrow3, adipose  tissue4 or birth-associated tissues—such as umbilical 
 cord5, cord  blood6,  decidua7 and  placenta8—due to their ease of obtainment. In contrast to other tissue sources, 
MenSCs collection from menstrual fluid is non-invasive, allows the isolation of a large number of cells and it 
is exempted from ethical dilemmas. All those properties have boosted their use in several pre-clinical  models9 
and some early-stage clinical  trials10.
The initial use of bone marrow and adipose-derived MSCs has generated extensive literature regarding the 
therapeutic role of MSCs. Their actions are known to be mediated by paracrine mechanisms, which provide 
a myriad of pleiotropic effects including angiogenic, anti-apoptotic and immunomodulatory  properties11,12. 
Among all the effects displayed, MSCs ability to modulate the immune system stands as a promising tool for the 
treatment of  inflammation13,14.
The immunomodulatory effects of MSCs are mainly dependent on the release of cytokines and anti-inflam-
matory factors, although cell–cell contact through the action of different ligands has also been  described15–17. 
Since the tissue source is a factor that might contribute to the particular functional properties and effects exerted 
by MSCs, one must be cautious when extrapolating the immunomodulatory properties of MSCs from different 
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 origins2,18–21. Bearing this in mind, it becomes necessary to understand the specific mechanisms of action by 
which MenSCs modulate immune populations.
Several studies have described MenSCs effects in different models of inflammation such as experimental 
 colitis22,23, lipopolysaccharide (LPS)-induced  injury24,25 or polymicrobial  sepsis26. However, these studies are 
focused on the systemic outcome of the treatment—e.g. survival rates or reduction of histopathological dam-
age—or the direct impact of MenSCs on T and B cell populations.
Macrophages are essential mediators of the innate immune response and play a crucial role in the develop-
ment and maintenance of  inflammation27. To date, the impact of MenSCs on macrophage function is unknown. 
To better aid clinical translation of MenSCs, unravelling their overall effect in the inflammatory process is 
needed. Therefore, studies of the impact of MenSCs on key players of inflammation, such as macrophages, could 
substantially contribute to understand their mode of action during the treatment of inflammatory disorders.
The purpose of this study was to evaluate the immunomodulatory effects that MenSCs have on macrophages 
during the early stages of acute inflammation using two mouse models: a thioglycollate (TGC)-elicited peritonitis 
model and a monobacterial sepsis model induced by Salmonella Typhimurium strains. We analysed the effect 
that the presence of MenSCs had on the recruitment of macrophages and other innate immune cells—such as 
neutrophils and inflammatory monocytes—and measured general parameters to monitor the inflammatory 
status of the mice. In addition, we studied the direct effect that MenSCs had on human macrophage functional 
properties, such as phagocytosis and bacterial clearance through the production of oxygen reactive intermediates.
Results
Injection of MenSCs alters the number and percentage of innate immune populations recruited 
to the peritoneum in a TGC‑elicited peritonitis mouse model. Firstly, we confirmed that the iso-
lated MenSCs were equivalent to those previously  reported1,28 by comparing morphological and phenotypic 
characteristics. Freshly isolated MenSCs exhibited a fibroblast-like shape when cultured on plastic (Fig. S1), were 
able to differentiate in vitro into osteoblasts, adipocytes and chondroblasts (data not shown), and showed a char-
acteristic MSCs surface marker phenotype (Fig. 1a). They were positive for commonly identified MSC surface 
markers such as CD9, CD29, CD44, CD73, CD90, CD105 and CD146, exhibited a low expression of the bone 
marrow progenitor cell marker CD117 and were negative for hematopoietic and endothelial markers including 
CD14, CD34, CD38, CD45, CD133 and HLA-DR. All the characteristics previously described make MenSCs 
meet minimal criteria to be considered human  MSCs29.
MSCs have been described as immune response modulators, showing differential effects depending on their 
tissue  source2,18–21. To evaluate the direct impact that MenSCs have on innate immune cells recruitment at the 
onset of inflammation, we administered MenSCs into a TGC-elicited peritonitis mouse model. In this model, 
TGC acts as an eliciting agent responsible for recruiting a large number of innate immune cells to the site of 
 injection30. The influx of neutrophils reach peak levels between 4 and 24 h after TGC injection, while mac-
rophage start their recruitment at 24 h and reach peak levels at 3–4  days31–33. MenSCs were intraperitoneally 
(IP) administered at either 4 h or 24 h after TGC injection; as controls, PBS, TGC alone or MenSCs alone were 
used (Fig. 1b). At day 5, mice were sacrificed, and peritoneal lavages were recovered to characterise the number 
and phenotype of recruited cells (Fig. 1c–f).
The number of cells recruited when MenSCs were administered 4 h after TGC treatment (T-MenSC-4 h) 
was similar to that of the TGC control group (1.1 ×  107 ± 4.2 ×  105 and 1.1 ×  107 ± 5.6 ×  105 respectively), while 
MenSCs injected at 24 h (T-MenSC-24 h) significantly reduced the total number of cells recruited (3.5 ×  106 ± 4.7 
×  105, p < 0.0001) (Fig. 1c). Moreover, recruited cell numbers were not affected by administration of MenSCs 
alone compared to the PBS group (1.8 ×  106 ± 3 ×  105 and 1.8 ×  106 ± 2.8 ×  105 respectively).
To fully characterise peritoneal recruited cells, their phenotype was assessed by flow cytometry. Macrophages 
(F4-80+/CD11b+), the main population of immune cells recruited in the TGC experimental conditions (7.4 × 
 106 ± 5 ×  105 cells), were significantly reduced in T-MenSC-4 h (6.1 ×  106 ± 8.2 ×  105 cells, p < 0.01) and dra-
matically reduced in T-MenSC-24 h (8.2 ×  105 ± 1.5 ×  105 cells, p < 0.0001) mice compared to single TGC group 
(Fig. 1d). In addition, while T-MenSC-24 h and single TGC group had a similar number of neutrophils (Ly-6G+/
CD11b+) (4 ×  105 ± 1 ×  105 cells and 8 ×  105 ± 1.7 ×  105 respectively), T-MenSC-4 h showed a statistically signifi-
cant increment of cells for this population (3.1 ×  106 ± 1.5 ×  105 cells, p < 0.0001) (Fig. 1d). Regarding the absolute 
number of inflammatory monocytes (Ly-6C+/CD11b+), no significant differences were observed between any 
of the experimental groups (Fig. 1d).
To determine whether the proportion of each immune population recruited was affected by MenSCs admin-
istration, the percentage of cells was also studied (Fig. 1e,f). We observed a progressive reduction of the per-
centage of macrophages in T-MenSC-4 h (58% ± 4.4, p < 0.0001) and T-MenSC-24 h (37% ± 3.3, p < 0.0001) 
compared to the TGC group (84% ± 2.3), while the neutrophil percentages increased significantly in both groups, 
T-MenSC-4 h (26% ± 1.8, p < 0.0001) and T-MenSC-24 h (18% ± 2.2, p < 0.01), in comparison to the TGC group 
(6% ± 1.6) (Fig. 1e,f). The percentage of inflammatory monocytes (Ly-6C+/CD11b+) in T-MenSC-24 h group 
was significantly increased (11% ± 1.9, p < 0.05) compared to the TGC group (2% ± 0.8) (Fig. 1e,f). Notably, 
when MenSCs were administered alone the percentage of macrophages recruited (46% ± 5.7, p < 0.0001) was 
significantly reduced compared to the PBS group (80% ± 4.5) (Fig. 1e).
Interestingly, while collecting the peritoneal lavage cells, a nodular structure was observed in the mice peri-
toneum of the T-MenSC-24 h injection group, which was subsequently analysed.
Characterisation of the peritoneal aggregates generated after TGC + MenSCs injection in 
mice. Aggregates observed during the peritoneal exam of T-MenSCs-24 h mice were subjected to macro-
scopic evaluation, cryosectioned and analysed by optical and confocal microscopy (Fig. 2). Macroscopically, 
3
Vol.:(0123456789)
Scientific Reports |        (2020) 10:21389  | https://doi.org/10.1038/s41598-020-78423-x
www.nature.com/scientificreports/
Figure 1.  Effects of MenSCs in a TGC-elicited peritonitis mouse model. (a) MenSCs phenotype assessment 
by flow cytometry. (b) Overview of mouse model TGC-elicited peritonitis and MenSCs treatment. (c) 
Total number of cells recruited in the peritoneal cavity 4 days after TGC administration. (d,e) Phenotypic 
characterisation of the cells recovered from the peritoneal lavage. Macrophage population was gated as 
F4-80+/CD11b+, neutrophils as Ly-6G+/CD11b+ and inflammatory monocytes as Ly-6C+/CD11b+. Results are 
represented as mean ± SEM (n = 4–9 mice per experimental group). (f) Representative flow cytometry analysis 
of mice peritoneal lavage from TGC, T + MenSCs (4 h) and T + MenSCs (24 h) experimental groups. All 
experiments were performed using 4 different MenSCs donors. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. 
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Figure 2.  Histopathological evaluation of the nodule generated after T + MenSCs administration. (a) 
Representative image of the nodule. (top, arrowhead) Peritoneum location 3 days after MenSCs administration 
under the TGC inflammatory insult. (bottom) Nodules recovered from mice injected with TGC + MenSCs-24 h. 
(b–f) Representative images of nodules taken by optical microscopy. (b) Longitudinal and (c) cross H&E 
stained sections from a paraffin embedded sample. 20 × magnification of the (d) peripheral and (e) central 
area of the structure. (f) Human  cytokeratin+ cells within the aggregates. (g) MenSCs, (h) macrophage and (i) 
neutrophil populations distributed within the OCT-frozen structure as determined by laser confocal microscopy 
after staining with the appropriate antibodies: (g anti-human  nuclei+-AF488; h anti-F4/80+-AF488; i anti-Ly-
6G+-AF594). A total of 3 different nodules were histopathologically characterised.
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they could be defined as solid, white nodules of considerable size (0.5–1 cm) (Fig. 2a). The H&E stained sections 
showed no sign of necrosis and revealed a mixed cell population (Fig. 2b–e). In particular, an accumulation of 
cells was observed at the periphery of the structure, whereas the central zone was occupied by a lax stroma (fat). 
At higher magnifications, polymorphonuclear cells were identified peripherally (Fig. 2d,e), while a population 
of human  cytokeratin+ cells was found within the stromal compartment (Fig. 2f).
Confocal analysis displayed a uniform distribution of anti-human  nuclei+ cells throughout the nodule 
(Fig. 2g). Macrophages (F4/80+) were identified as the main cellular component, forming clusters within the 
internal core as well as on the outer surface of the nodular structure (Fig. 2h). Neutrophils (Ly-6G+) were also 
present, limiting their location to the periphery (Fig. 2i) as previously suggested by the H&E sections (Fig. 2d).
MenSCs exacerbate Salmonella Typhimurium infection in a sepsis mouse model. We further 
explored the effects of MenSCs in a model of systemic typhoid-like  disease34 caused by Salmonella enterica Sero-
var Typhimurium (Salmonella) infection in susceptible mice. In this model, a mix of wild type (ST) and attenu-
ated (SseB−)35 Salmonella strains are co-injected (Fig. 3a). MenSCs were IP administered 4 h after the injection 
of Salmonella, that is, at the onset of  sepsis36 (Fig. 3a).
Twenty-four hours after sepsis induction, the peritoneal cell count of Salmonella + MenSCs mice showed a 
significant reduction in the influx of cell populations (6.1 ×  106 cells ± 5.2 ×  105, p < 0.001) compared to Salmonella 
group (9.7 ×  106 ± 7.9 ×  105) (Fig. 3b). In this control Salmonella group, the main immune populations com-
prised of neutrophils (Ly-6G+/CD11b+) (4.2 ×  106 ± 5.7 ×  105) followed by macrophages (F4-80+/CD11b+) (2.9 × 
 106 ± 2.7 ×  105) (Fig. 3c). In contrast, the Salmonella + MenSCs group showed similar numbers of macrophages 
and neutrophils (1.8 ×  106 ± 4 ×  105 and 1.8 ×  106 ± 2.7 ×  105 respectively), being both populations significantly 
fewer in number compared to Salmonella group (p < 0.05, p < 0.001 respectively) (Fig. 3c). As for inflammatory 
monocytes (Ly-6C+/CD11b+), no significant changes in cell number were detected between groups (Fig. 3c).
Analyses of the percentage populations also showed a statistically significant reduction in the percentage 
of both neutrophils (22.5% ± 2.7, p < 0.0001) and macrophages (24% ± 1.6, p < 0.0001) compared to the control 
Salmonella group (42% ± 3.3 and 32% ± 1.5 respectively), being consistent with the reduction in number of 
positive cells (Fig. 3d,e). Regarding the percentage of inflammatory monocytes, no significant differences were 
detected between experimental groups (Fig. 3d). Interestingly, while using the Salmonella model, no peritoneal 
cell aggregation was detected during the collection of the peritoneal lavage cells.
To evaluate the septic state of the mice, we monitored the weight loss (Fig. 3f), spleen inflammation (Fig. 3g) 
and colony-forming unit (CFU) burden in infected organs and tissues such as the spleen, mesenteric nodes and 
peritoneal fluid (Fig. 3h). Although no differences in body and spleen weight were found between Salmonella 
and Salmonella + MenSCs experimental groups, the bacterial load in MenSCs-injected mice increased remark-
ably in the spleen compared to the Salmonella group indicating significantly inferior bacteria clearance (Fig. 3h, 
see Table S1) and suggesting an increment in the proliferative activity of the  bacteria35,37. This pattern was also 
observed for peritoneal fluid and mesenteric nodes (Fig. 3h, see Table S1).
During early sepsis, there is an intense production of pro-inflammatory cytokines which leads to multiple 
organ failure and eventually  death36. To give insight into the peritoneal inflammatory context, levels of mRNA 
expression of pro- (inducible nitric oxide synthase (Nos2), tumour necrosis factor-α (Tnf)) and anti-inflammatory 
mediators (Il10, Tgfb) were also analysed (Fig. 3i). Nos2 expression was threefold upregulated in the peritoneal 
fluid of Salmonella + MenSCs mice compared to Salmonella mice. This pattern was also found in Il10 expression 
(twofold increase) whereas no changes were observed in Tgfb and Tnf mRNA levels.
Co‑culture with MenSCs results in bacterial killing impairment of the human macrophage cell 
line THP‑1. The previous results derived from the sepsis mouse model suggest that the role of macrophages 
in this bacterial infection could be modulated by MenSCs. To decipher whether MenSCs may affect bacterial 
clearance capability of human macrophages we evaluated the phenotype, phagocytic and killing capacity of 
PMA-differentiated THP-1 (THP-1PMA) cells in vitro.
First, we co-cultured THP-1PMA with MenSCs for 72 h and analysed the surface expression of macrophage 
markers (CD14, CD16, CD80, CD86 and CD11b) to determine whether their differentiation state could be 
affected by MenSCs (Fig. 4a). Co-cultured THP-1PMA showed a significant decrease in the expression of the 
co-stimulatory molecules CD80 (17-fold reduction, p < 0.0001) and CD86 (1.5-fold reduction, p < 0.0001), the 
marker for classical macrophages CD16 (15-fold reduction, p < 0.01), and the monocyte-to-macrophage dif-
ferentiation marker CD11b (1.2-fold reduction, p < 0.05), suggesting a switch to a more regulatory phenotype 
(Fig. 4a). Moreover, co-culture with MenSCs increased THP-1PMA CD14 surface expression (twofold increase in 
the number of  CD14high cells, p < 0.001) compared to THP-1PMA cultured alone (Fig. 4b).
To evaluate the phagocytic capacity of THP-1PMA co-cultured with MenSCs (ratio 4:1) for 48 h, they were 
then challenged with SseB− for 30 and 60 min. MenSCs co-culture significantly increased the phagocytic capac-
ity of THP-1PMA compared to THP-1PMA cultured alone (30 min 1.5-fold increase p < 0.0001, 60 min 1.1-fold 
increase p < 0.05) (Fig. 4c).
In order to measure macrophage effectiveness in blocking Salmonella intracellular replication, we performed a 
gentamicin protection assay at 6, 24 and 48 h (Fig. 4d). Six hours after the bacteria challenge, the number of viable 
bacteria recovered from THP-1PMA co-cultured with MenSCs was similar to that without co-culture treatment. 
However, at both 24 h and 48 h after SseB− exposure, there was a significant increase of bacteria recovered from 
THP-1PMA co-cultured with MenSCs compared to THP-1PMA cultured alone (24 h 1.5-fold increase p < 0.0001, 
48 h 2.6-fold increase p < 0.0001) (Fig. 4d), indicating that MenSCs severely impaired the bacteria killing ability 
of THP-1PMA, and favoured Salmonella  proliferation37.
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To further evaluate whether the inefficient microbicide effects were due to a defective respiratory burst, 
reactive oxygen species (ROS) production was measured (Fig. 4e). DCFDA oxidation measurement showed 
a significant reduction in ROS production by THP-1PMA directly co-cultured with MenSCs at all time points 
compared to THP-1PMA cultured alone. Hence, in the context of in vitro SseB− infection, MenSCs might dimin-
ish ROS production in human THP-1PMA and as a consequence bacteria clearance is reduced. Interestingly, 
THP-1PMA ROS production was diminished even though MenSCs primed with SseB− were also able to generate 
microbicidal oxygen intermediates (Fig. 4e).
Discussion
The clinical potential of MenSCs is undeniable. From a technical perspective, their non-invasive collection and 
exemption from ethical concerns are advantages that make MenSCs good alternatives to other MSCs sources. On 
the other hand, from a therapeutic perspective, MenSCs general immunomodulatory  properties1,2 are a promis-
ing feature to explore for future cell-based therapies, especially for those involving the treatment of immune 
disorders. However, the extent of their modulatory effects on inflammation remain poorly understood. To fur-
ther unravel their properties, we analysed MenSCs and macrophage crosstalk in two different models of acute 
peritonitis, a germ free TGC-elicited peritonitis model and a monobacterial sepsis model induced by Salmonella 
Typhimurium strains. Each model displays a particular inflammatory context, which allows us to study MenSCs 
impact on macrophages in a tightly controlled setting.
We found that, when MenSCs were injected 4 or 24 h after the TGC administration, the number and percent-
age of macrophages recruited to the peritoneum decreased. Interestingly, this reduction was more evident on 
the T-MenSCs-24 h mice group where it correlated with the appearance of peritoneal aggregates. It is not the 
first time that peritoneal aggregates are found after the administration of MSCs. Using a colitis mouse model, 
Sala et al.38 found that mouse bone marrow and human adipose MSCs formed aggregates in the peritoneal 
cavity when IP injected in  mice38. Considering the ability of MenSCs to identify sites of injury and direct their 
migration towards  them26,39,40, we hypothesise that MenSCs injected at the 24 h time point identify the local 
inflammatory milieu and use the peritoneal adipose tissue—close to the site of injection—as a scaffold to recruit 
and modulate peritoneal cell populations. The internal organisation of the aggregates seems to support this 
hypothesis, where MenSCs are located within the structure whereas macrophages can be found peripherally, as 
if they were later recruited.
The distribution of macrophages within the peritoneal aggregates also suggest bloodstream recruitment, 
as they could be found clustered surrounding the adipose tissue blood vessels. Although further studies are 
needed, both the systemic and local attraction could be mediated by the chemokine CCL2, which is responsible 
for recruiting monocytes and  macrophages14 and has been found to be constitutively expressed by  MenSCs41.
The presence of MenSCs in the TGC-elicited peritonitis also affected the influx of other innate immune popu-
lations. For instance, the percentage of neutrophils recruited towards the peritoneum, both at 4 h and 24 h hours 
after TGC administration, was significantly increased. Likewise, neutrophils were also found in the peritoneal 
aggregates, suggesting that MenSCs might promote local neutrophil recruitment. Although the specific impact 
of MenSCs on neutrophils is outside the scope of this study, it would be very informative to address whether 
MenSCs can modulate neutrophil lifespan and chemotaxis.
In the monobacterial sepsis model, the administration of MenSCs reduced the number of phagocytes—
macrophages and neutrophils—recruited to the peritoneum. To determine whether the diminished microbi-
cidal activity observed in the peritoneal fluid was not only due to the macrophage cell number but also to 
their phenotype, we analysed a set of classical pro- (Nos2, Tnf) and anti-inflammatory mediators (Il10, Tgfb). 
The upregulation of Nos2 and Il10 mRNA levels in the peritoneal fluid of MenSCs-treated mice suggests that 
MenSCs may promote a regulatory macrophage phenotype. Regulatory macrophages are known to possess an 
hybrid phenotype which shares M1 (NOS2) and M2 (IL-10, arginase-1) macrophage classical markers, with the 
main function of reestablishing tissue  homeostasis42–45. They also display poor bactericidal  properties42 mainly 
due to IL-10  expression46. Furthermore, the secretion of IL-10 by regulatory macrophages can prevent neutro-
phils migrating into the inflamed  tissue47, supporting the significant decrease in neutrophil recruitment after 
MenSCs injection. Far from considering a contradiction the apparently opposite results regarding neutrophil 
recruitment in the two inflammation models, it does highlight the dynamic role of MenSCs in orchestrating the 
inflammatory response. For the TGC-elicited peritonitis, MenSCs face a germ free inflammation model mainly 
driven by damage-associated molecular patterns (DAMPs)48 and with self-resolution capacity. In contrast, the 
Figure 3.  Effects of MenSCs in a sepsis mouse model. (a) Overview of a sepsis mouse model induced by S. 
Typhimurium injection and MenSCs treatment. (b) Total number of cells recruited in the peritoneal cavity 
24 h after MenSCs administration. (c,d) Phenotypic characterisation of the cells recovered from the peritoneal 
lavage. Macrophage population was gated as F4-80+/CD11b+, neutrophils as Ly-6G+/CD11b+ and inflammatory 
monocytes as Ly-6C+/CD11b+. (e) Representative flow cytometry analysis of mice peritoneal lavage from 
Salmonella and S + MenSCs experimental groups. (f) Mice body weight represented as [weight before sacrifice/
initial weight] × 100. (g) Spleen weight relativised to the mice body weight before sacrifice. (h) Bacterial load in 
spleen, peritoneal fluid and mesenteric nodes obtained from Salmonella-infected mice treated with and without 
MenSCs. (i) Relative mRNA expression of Nos2, Tnf, Il10 and Tgfb in peritoneal fluid lysates referred to mRNA 
expression levels in infected mice without MenSCs injection. Results are represented as mean ± SEM (n = 12–13 
mice per experimental group). All experiments were performed using 4 different MenSCs donors. *p < 0.05, 
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monobacterial sepsis model is perpetuated by pathogen-associated molecular patterns (PAMPs)49, priming dif-
ferent responses from MenSCs. Ultimately, all responses suggest a role for MenSCs in preventing tissue damage 
and promoting homeostasis.
MenSCs administration significantly enhanced peritoneal bacterial load and bacterial dissemination to spleen 
and mesenteric nodes suggesting a poor control of bacterial replication and a potential inability to effectively 
clear this  pathogen37. The additional in vitro experiments performed with human THP-1PMA cells provided 
further understanding of the effect of MenSCs on macrophage functional properties. Interestingly, when co-
cultured with MenSCs, THP-1PMA cells experienced a time-dependent increase in bacterial internalization. This 
macrophage enhanced phagocytic activity has also been detected using MSCs from other tissue  sources44,45,50 
supporting the ability of MenSCs to reprogram macrophages. The increase in CD14 surface expression further 
supports this phagocytic activity, as macrophages can internalise Gram-negative bacteria by a CD14-dependent 
 mechanism51. In addition to the upregulation of CD14, a phenotypic switch of the THP-1PMA cells after Men-
SCs co-culture was evidenced by the reduced expression of CD80/CD86, which are heavily involved in antigen 
T-cell presentation. This attenuation of antigen presentation capacity could indicate a move to a more regulatory 
macrophage  phenotype52.
Figure 4.  Evaluation of the activity of PMA-differentiated THP-1 cells co-cultured with MenSCs. PMA-
differentiated THP-1 cells (THP-1PMA) were co-cultured or not with MenSCs (ratio 4:1) for 48 h (c–e) or 72 h 
(a,b). (a) Phenotypic characterisation and (b) CD14 specific expression pattern of THP-1PMA. (c) THP-1PMA 
intake of Salmonella SseB− after 30 min and 60 min of bacteria exposure. (d) Gentamicin protection assay 
reflecting bacteria killing time lapse of THP-1PMA after exposure to Salmonella SseB− for 60 min. (e) ROS 
production in vitro was measured by DCFDA oxidation. Results are represented as mean ± SEM of 3–6 different 
MenSCs, derived from different donors (n = 3–10 replicates). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. 
RU relative units, CFU colony-forming units.
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Phagocytic cells display a variety of killing  mechanisms53. During Salmonella infection, the generation of 
reactive oxygen species (ROS) has been found to be critical to effectively control intracellular multiplication and 
survival of the different Salmonella  strains54–57. In vitro, we detected a significant decrease in ROS production 
when THP-1PMA cells were directly co-cultured with MenSCs, suggesting that the defective killing observed 
might be due to a diminished ROS generation in response to bacteria stimuli.
The use of MenSCs as a therapeutic strategy for sepsis has been previously  outlined26. In 2015, Alcayaga-
Miranda et al. evaluated the therapeutic effect of MenSCs in a cecal ligation and puncture (CLP) sepsis mouse 
model showing that MenSCs IP administered improved overall survival and rescued mice from an exacerbated 
inflammatory  response26. Similarly, MenSCs injection on a LPS-induced acute lung injury mouse model attenu-
ated lung histopathological damage and inflammation and induced IL-10 upregulation in the bronchoalveolar 
fluid (BALF)24. Moreover, a reduction in the BALF cell count was found, similar to what we observed in the mice 
peritoneal fluid of our sepsis model. However, there are certain key differences between these sepsis models and 
our own. Firstly, they both make use of C57BL6/j mice, a prototypical  Th1-dominant mouse strain, whereas we 
employ BALB/c mice, a  Th2- dominant  one58. This specific background can condition the animal inflammatory 
milieu and therefore the context encountered by MenSCs when they are injected. Secondly, the mechanism 
of infection and multiplication differs between bacterial strains. The CLP model is based on commensal bac-
teria whose multiplication method is  extracellular59 while, in our case, Salmonella strains cause intracellular 
 infection56. In the same  manuscript26, Alcayaga-Miranda et al. demonstrated in vitro that MenSCs showed 
anti-microbial activity mediated, at least in part, by the microbicidal peptide hepcidin. We agree with this direct 
anti-microbial effect of MenSCs, as we have shown that challenging MenSCs with Salmonella strains triggers 
their generation of ROS, as well as their phagocytic and killing capacity (data not shown). However, the reduc-
tion in the peritoneal phagocytes recruitment observed in both TGC and S. Typhimurium model, along with 
the in vitro human reprogramming of THP-1PMA cells when co-cultured with MenSCs, reinforces the hypothesis 
of MenSCs acting as key modulators of inflammation through their direct action on innate immune cells rather 
than through their specific anti-microbial properties.
Although our work highlights the key role of MenSCs in modulating macrophage response during acute 
inflammation, there are some limitations that still need to be overcome. For instance, determining the mediators 
responsible for MenSCs effects as well as the molecular pathways involved in the immunomodulatory effects are 
pending tasks which will provide extremely valuable information for MenSCs translation to clinic. In addition, 
extending this study to other innate immune cell populations, such as neutrophils, will contribute to a better 
understanding of MenSCs inflammatory sensing properties. The relevance of this work is based on giving new 
evidence of MenSCs as sensors and switchers of  inflammation13, stressing that this property can boost their 
therapeutic beneficial effects but must also be taken into account in future clinical applications. We believe that 
the data presented here will set the scene for further and thorough studies about MenSCs administration for the 
treatment of inflammatory diseases.
Methods
Ethical approval and consent to participate. All protocols and methods described in this research 
article were performed in accordance with the relevant guidelines and regulations of the University of Granada 
(UGR) and approved by the Research and Ethics Committee of the same institution. Committee’s reference 
number for human samples collection: 186/CEIH/2016.
Committee’s reference number for animal studies: 12/12/2016-179/143-CEEA-OH-2015 and 12/12/2016-
179 JJAA.
MenSCs isolation and culture. Menstrual blood samples were obtained from 15 volunteer women at ages 
ranged between 20 and 35 years with a regular menstrual cycle. The recruited women had no gynaecological or 
autoimmune disorders, claimed to be HIV and HCV negative and were not using hormonal oral contraceptives 
(exclusion criteria). Prior informed consent was obtained from the volunteers.
MenSCs were isolated from menstrual blood collected with menstrual cups or tampons the second day of the 
menstrual cycle. Mononuclear cells were separated by density gradient centrifugation with Ficoll-Paque (Merck 
KGaA, Darmstadt, Germany) and transferred into Opti-MEM media supplemented with 1% penicillin–strep-
tomycin, amphotericin B and 3% heat-inactivated fetal bovine serum (FBS) (all from Thermo Fisher Scientific, 
Waltham MA, USA). MenSCs were cultured at 37 °C in a 5%  CO2 humidified atmosphere with media changes 
every 3–4 days. All the experiments were performed using MenSCs at early passages (P2-P6).
MenSCs optical images were taken by a Leica microscope (DM IL LED, Leica Camera AG, Wetzlar, Germany) 
equipped with a charge-coupled device (CCD) camera.
THP‑1 cell culture and differentiation. THP-1 cells were grown in RPMI 1640 (GE Healthcare, Chi-
cago, IL, USA) media supplemented with 1 mM Sodium Pyruvate, 2 mM l-Glutamine, 25 mM HEPES buffer 
and 10% heat-inactivated FBS (all from Thermo Fisher Scientific). The cells were cultured at 37 °C in a 5%  CO2 
humidified atmosphere with media changes every 3–4 days. In order to differentiate them to naïve macrophages, 
THP-1 cells were incubated with 10 ng/ml phorbol 12-myristate 13-acetate (PMA, Merck) for 24 h and cultured 
in Opti-MEM media supplemented with 1% penicillin–streptomycin, amphotericin B and 3% heat-inactivated 
FBS for additional 24 h prior to their use.
For phenotype assessment studies, 4 ×  105 differentiated THP-1 cells/well were cultured in a 6-well plate 
with Opti-MEM supplemented media and a 0.4-μm-pore size Corning Transwell inserts (Merck) on top of the 
plate, where 1 ×  105 MenSCs were seeded (ratio 4:1). The Transwell system was incubated for further 72 h. PMA-
differentiated THP-1 cells without co-culture were used as a control.
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Bacterial strains. Wild type Salmonella enterica subsp. enterica serovar Typhimurium (NCTC 12023) and 
attenuated resistant to ampicillin Salmonella enterica subsp. enterica SseB− (MvP643, p3232) strains were rou-
tinely grown overnight under sterile conditions in Luria–Bertani (LB) broth and LB with 100 µg/ml of ampicil-
lin, respectively. Both bacterial strains were kindly donated by Dr. Michael Hensel (University of Osnabrück, 
Germany). When required, estimation of bacterial concentration was measured using a spectrophotometer 
(Spectronic Genesys 8, Spectronic Instruments).
Animals. Eight-to ten-week-old female BALB/c mice were group-housed at the Animal Facility of Centro 
de Investigación Biomédica (UGR) in stable humidity and temperature conditions on a 12:12-h light/dark cycle, 
with free access to food and water.
TGC‑elicited peritonitis mouse model. In order to establish acute sterile peritonitis, 4% fluid TGC 
medium (Becton, Dickinson and Company (BD), Franklin Lakes, NJ, USA) was administered via intraperi-
toneal (IP) injection. Four or 24 h later, 2 ×  106 MenSCs were also IP administered. A single injection of TGC 
or phosphate-buffered saline (PBS) administration were used as control groups and single administration of 
MenSCs was also evaluated.
Mice were euthanized by  CO2 inhalation 4 days after TGC injection in order to collect peritoneal exudates. 
Briefly, 8 ml of ice-cold PBS were IP administered and the exudates were harvested after 1 min of peritoneal 
massage. This process was repeated up to three times, collecting a total volume of 24 ml. After centrifugation at 
1500 rpm for 5 min, the cell pellets were resuspended in PBS, counted using a hemocytometer (ZMB007, Zuzi, 
Spain) and supplemented with 0.5% bovine serum albumin (BSA)-2 mM EDTA for flow cytometry assessment.
Monobacterial sepsis model. A model of systemic typhoid-like disease was generated by infecting mice 
with Salmonella enterica subsp. enterica serovar Typhimurium (Salmonella) strains. Since the WT Salmonella 
strain (ST) cannot by eliminated by mice, its injection is accompanied by the Salmonella attenuated strain SseB− 
(SseB−), which lacks a pathogenicity island 2 loci thus resulting in attenuated virulence and defective intracel-
lular  surviving35, allowing to monitor the course of the infection resolution. Hence, mice were IP challenged with 
2.5 ×  104 ST + 2.5 ×  104 SseB− bacteria of Salmonella strains and four hours later, coincident with an acute phase 
of the disease, 2·106 MenSCs were also IP administered. A single injection of both Salmonella strains was used 
as an infected control group.
Mice were euthanized by  CO2 inhalation 24 h after infection. Peritoneal exudates were collected to character-
ise the phenotype of cells recruited as described above. Mice’s spleen and mesenteric nodes were homogenized 
in PBS and plated in LB and LB + ampicillin (100 µg/ml) agar plates under sterile conditions to determine the 
bacterial load by counting the number of colonies. Peritoneal fluid bacterial burden was also analysed.
Body weight was monitored prior to Salmonella injection and before sacrifice. Spleen weight was also meas-
ured and relativised to the mice body weight before sacrifice.
Flow cytometry analysis. Phenotype assessment of MenSCs and PMA-differentiated THP-1 cells was 
carried out by flow cytometry using direct or indirect staining with a panel of antibodies (Table S2). Briefly, cells 
were washed with PBS supplemented with 0.5% BSA and 2 mM EDTA prior to incubation with the antibodies of 
interest or the proper isotype controls and secondary antibodies where appropriate. PMA-differentiated THP-1 
cells had an extra step with Fc-block (anti-CD16/CD32, BD) for 15 min prior to surface markers staining. After 
a 30-min incubation at 4 °C, samples were characterised on a FACSCalibur (BD) flow cytometer and analysed 
using FlowJo software (v.10, FlowJo LLC).
Regarding the animal studies, the peritoneal lavage cells were also incubated with Fc-block for 15 min prior to 
surface markers direct staining (Table S2). Appropriate isotype controls were also used. After 30 min incubation 
at 4 °C, samples were acquired on a FACSCanto II flow cytometer and analysed using FACSDiva software (BD). 
Gates set on forward and side angle light scatter were used to exclude dead cells and debris and the number of 
positive cells was calculated as [(%) positive cells x total cell count]/100.
Confocal microscopy and immunohistochemistry. Peritoneal aggregates were collected from the per-
itoneal cavity and snap-frozen in an OCT-filled mold (Tissue-Tek O.C.T Compound, Sakura SI Co. Ltd., Tokyo, 
Japan) immersed in isopentane on a liquid nitrogen-cooled metal surface. Samples were stored at − 80 °C until 
the cryosections were performed.
For confocal microscopy analysis, 7-μm thick cryosections were fixed in 3.7% paraformaldehyde (PFA). After 
rehydration with PBS, sections were blocked for 45 min at room temperature in PBS-Tween (0.1%)-BSA (5%) 
containing goat serum (5%) and Triton X-100 (0.2%). Then, slides were stained using anti-mouse F4/80, Ly-6G 
and anti-human nuclei (Table S2) overnight at 4 °C. After three washes with PBS-Tween (0.1%), sections were 
incubated where appropriate with secondary antibodies (Table S2) for 2 h at room temperature. The slides were 
counterstained with Hoechst 33258 (Merck) and mounted in Fluoroshield mounting media (Merck).
Confocal image acquisition was performed using a Nikon A1 confocal microscope (Nikon Instruments Inc., 
Tokyo, Japan) and the images were processed with the NIS-Elements AR 3.2 imaging software.
For the histopathological analysis, the peritoneal aggregates were embedded in paraffin, sectioned with a 
microtome, and stained with hematoxilin and eosin (H&E) solution. Histology analyses were assigned in a 
blinded fashion by a pathologist. The identification of human cells was performed using a human cytokeratin 
CAM 5.2 antibody labelled with peroxidase.
11
Vol.:(0123456789)
Scientific Reports |        (2020) 10:21389  | https://doi.org/10.1038/s41598-020-78423-x
www.nature.com/scientificreports/
Quantitative PCR. Total RNA was extracted from peritoneal exudates using the TRIzol reagent (Thermo 
Fisher Scientific). cDNA was synthesized using Access RT-PCR System kit (Promega Corporation, Madison, WI, 
USA) with oligo-dT primers and according to the manufacturer’s protocol.
For quantitative PCR, appropriate primers and FastStart Universal SYBR Green Master (Merck) were used 
according to the manufacturer’s instructions on a Quantstudio 3 Real-time PCR system (Applied Biosystems, 
Foster City, CA, USA).
Data were normalized to the expression of the housekeeping gene β-actin (Actb) and shown as fold change 
relative to mRNA expression levels in infected mice without MenSCs injection applying the  2− ΔCT formula.
Primer sequences are listed in Table S3.
Phagocytosis assay. To determine the phagocytic activity of PMA-differentiated THP-1 cells, 4 ×  105 
differentiated THP-1 cells/well were cultured in a 6-well plate with antibiotic-free Opti-MEM (3% FBS) and 
0.4-μm-pore size Corning Transwell inserts (Merck) on top of the plate, where 1 ×  105 MenSCs were seeded (ratio 
4:1). The Transwell system was incubated for further 48 h. PMA-differentiated THP-1 cells without co-culture 
were used as a control.
After co-culture, the Transwell inserts containing MenSCs were discarded and Salmonella Typhimurium 
SseB− was added to the THP-1 cells monolayer at a multiplicity of infection (MOI) of 25. Plates were centri-
fuged for 1 min at 3500 rpm to synchronize bacterial uptake and incubated at 37 °C for 30 or 60 min. After the 
indicated times, cells were washed three times with PBS to remove extracellular bacteria and lysed with 1 ml of 
0.5% Triton X-100 in miliQ water for 10 min at room temperature. Lysates were serially diluted and incubated 
in LB + ampicillin (100 µg/ml) agar plates overnight at 37ºC and the number of colonies was counted.
Gentamicin protection assay. Killing activity of PMA-differentiated THP-1 cells was measured using a 
gentamicin protection  assay60. Briefly, 4 ×  105 differentiated THP-1 cells/well were co-cultured or not with 1 × 
 105 MenSCs/well using a Transwell system as described above. After 48 h of co-culture, THP-1 cells were chal-
lenged with Salmonella Typhimurium SseB− at a MOI of 25 for 1 h at 37 °C. Once infection took place, cells were 
washed twice with PBS and the medium was supplemented with 100 µg/ml gentamicin (Thermo Fisher Scien-
tific) for 1 h to kill extracellular bacteria. Thereafter, fresh medium containing 10 µg/ml gentamicin was added 
and kept for 6, 24 and 48 h at 37 °C. At the indicated time points, cells were washed twice with PBS and lysed with 
1 ml of 0.5% Triton X-100 in miliQ water for 10 min at room temperature. Serial dilutions of the lysates were 
incubated in LB + ampicillin (100 µg/ml) agar plates overnight at 37 °C and colony-forming units (CFU) were 
counted. Cells fixed in PFA before the bacterial challenge were used as a killing negative control.
Intracellular ROS detection. Intracellular  H2O2 generation was measured using 2′,7-Dichlorofluorescin 
Diacetate (DCFDA, Merck) as previously  described54,61. Briefly, PMA-differentiated THP-1 cells were cultured 
in a dark—clear bottom—96-well microplate (5 ×  104 cells/well) with antibiotic-free Opti-MEM (3% FBS) and 
1.25 ×  104 MenSCs were directly seeded (ratio 4:1) continuing to be cultivated for an additional 48 h. PMA-
differentiated THP-1 cells and MenSCs without co-culture were used as controls.
After incubation, cells were stained in the diluted DCFDA solution (3 μM) at 37 °C for 1 h in the dark and 
then washed twice with PBS. Next, cells were stimulated with Salmonella Typhimurium SseB− at a MOI of 100 
and the fluorescence intensity was measured at different times in a plate reader (Synergy Neo2, Biotek Instru-
ments Inc., Winooski, VT, USA) with an excitation wavelength and emission wavelength set of 485 nm and 
535 nm respectively.
Results are expressed as fluorescent relative units (RU) after blank subtraction (DCFDA-unstimulated cells).
Statistical analysis. Results are expressed as the mean ± SEM. For the TGC-elicited peritonitis mouse 
model, statistical differences were determined using ordinary one or two-way ANOVA with Tukey’s multiple 
comparison post hoc test. N is ranged between 4 and 9 mice per experimental group.
Regarding the monobacterial sepsis model, the unpaired two-tailed Student’s t-test was used for body weight 
loss, spleen weight and total cell count whereas two-way ANOVA with Sidak’s multiple comparison post hoc 
test was used for phenotypic analysis, CFU quantification and mRNA expression levels. N is ranged between 12 
and 13 mice per experimental group.
For the in vitro assays statistical differences were determined using two-way ANOVA with Tukey’s (Phago-
cytosis, ROS production) or Sidak’s (Gentamicin protection assay, THP-1 phenotype assessment) post hoc tests. 
In this case, the number of replicates ranged from 3–10, using a minimum of 3 different MenSCs donors.
All the statistical analyses were performed using GraphPad Prism 6 (GraphPad Software). P values less 
than 0.05 were interpreted as statistically significant and represented as *p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001.
 Data availability
All data generated or analysed during this study are included in this published article and its supplementary 
information files.
Received: 12 June 2020; Accepted: 24 November 2020
12
Vol:.(1234567890)
Scientific Reports |        (2020) 10:21389  | https://doi.org/10.1038/s41598-020-78423-x
www.nature.com/scientificreports/
References
 1. Meng, X. et al. Endometrial regenerative cells: a novel stem cell population. J. Transl. Med. 5, 57 (2007).
 2. Alcayaga-Miranda, F. et al. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell 
support in comparison with bone marrow mesenchymal stem cells. Stem Cell Res. Ther. 6, 32 (2015).
 3. Polymeri, A., Giannobile, W. & Kaigler, D. Bone marrow stromal stem cells in tissue engineering and regenerative medicine. Horm. 
Metab. Res. 48, 700–713 (2016).
 4. Patrikoski, M., Mannerström, B. & Miettinen, S. Perspectives for clinical translation of adipose stromal/stem cells. Stem Cells Int. 
2019, 1–21 (2019).
 5. Batsali, K., Kastrinaki, M.-C., Papadaki, H. & Pontikoglou, C. Mesenchymal stem cells derived from Wharton’s jelly of the umbilical 
cord: biological properties and emerging clinical applications. Curr. Stem Cell Res. Ther. 8, 144–155 (2013).
 6. Roura, S., Pujal, J.-M., Gálvez-Montón, C. & Bayes-Genis, A. The role and potential of umbilical cord blood in an era of new 
therapies: a review. Stem Cell Res. Ther. 6, 123 (2015).
 7. Muñoz-Fernández, R. et al. Human predecidual stromal cells are mesenchymal stromal/stem cells and have a therapeutic effect 
in an immune-based mouse model of recurrent spontaneous abortion. Stem Cell Res. Ther. 10, 177 (2019).
 8. Mathew, S. A., Naik, C., Cahill, P. A. & Bhonde, R. R. Placental mesenchymal stromal cells as an alternative tool for therapeutic 
angiogenesis. Cell. Mol. Life Sci. 77, 253–265 (2020).
 9. Bozorgmehr, M. et al. Endometrial and menstrual blood mesenchymal stem/stromal cells: biological properties and clinical 
application. Front. Cell Dev. Biol. 8, (2020).
 10. Rodrigues, M. C. O. et al. Menstrual blood-derived stem cells: in vitro and in vivo characterization of functional effects. Adv. Exp. 
Med. Biol. 951, 111–121 (2016).
 11. Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726–736 (2008).
 12. Zhou, Y., Yamamoto, Y., Xiao, Z. & Ochiya, T. The immunomodulatory functions of mesenchymal stromal/stem cells mediated 
via paracrine activity. J. Clin. Med. 8, 1025 (2019).
 13. Bernardo, M. E. et al. Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 13, 392–402 (2013).
 14. Le Blanc, K. & Davies, L. C. Mesenchymal stromal cells and the innate immune response. Immunol. Lett. 168, 140–146 (2015).
 15. Elman, J. S., Li, M., Wang, F., Gimble, J. M. & Parekkadan, B. A comparison of adipose and bone marrow-derived mesenchymal 
stromal cell secreted factors in the treatment of systemic inflammation. J. Inflamm. 11, 1 (2014).
 16. Shi, Y. et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat. Rev. Nephrol. 
14, 493–507 (2018).
 17. de Castro, L. L., Lopes-Pacheco, M., Weiss, D. J., Cruz, F. F. & Rocco, P. R. M. Current understanding of the immunosuppressive 
properties of mesenchymal stromal cells. J. Mol. Med. 97, 605–618 (2019).
 18. Mattar, P. & Bieback, K. Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue 
mesenchymal stromal cells. Front. Immunol. 6, 1–8 (2015).
 19. Ren, H., Zhang, Q., Wang, J. & Pan, R. Comparative effects of umbilical cord- and menstrual blood-derived MSCs in repairing 
acute lung injury. Stem Cells Int. 2018, 1–9 (2018).
 20. Fathi-Kazerooni, M. et al. Comparative restoration of acute liver failure by menstrual blood stem cells compared with bone marrow 
stem cells in mice model. Cytotherapy 19, 1474–1490 (2017).
 21. Cuenca, J. et al. The reparative abilities of menstrual stem cells modulate the wound matrix signals and improve cutaneous regen-
eration. Front. Physiol. 9, 1–19 (2018).
 22. Lv, Y. et al. Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice. J. Transl. Med. 12, 1–11 
(2014).
 23. Xu, X. et al. Treatment of experimental colitis by endometrial regenerative cells through regulation of B lymphocytes in mice. Stem 
Cell Res. Ther. 9, 1–12 (2018).
 24. Xiang, B. et al. Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute 
lung injury. Int. J. Mol. Sci. 18, 689 (2017).
 25. Jin, W. et al. Stromal cell-derived factor-1 enhances the therapeutic effects of human endometrial regenerative cells in a mouse 
sepsis model. Stem Cells Int. 2020, 1–14 (2020).
 26. Alcayaga-Miranda, F. et al. Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival 
in sepsis. Stem Cell Res. Ther. 6, 199 (2015).
 27. Fujiwara, N. & Kobayashi, K. Macrophages in Inflammation. Curr. Drug Target Inflam. Allergy 4, 281–286 (2005).
 28. Ruiz Magaña, M. J. et al. Endometrial and decidual stromal precursors show a different decidualization capacity. Reproduction 
160, 83–91 (2020).
 29. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular 
Therapy position statement. Cytotherapy 8, 315–317 (2006).
 30. Wang, G. et al. Cutting Edge: Slamf8 is a negative regulator of Nox2 activity in macrophages. J. Immunol. 188, 5829–5832 (2012).
 31. Leijh, P. C., van Zwet, T. L., ter Kuile, M. N. & van Furth, R. Effect of thioglycolate on phagocytic and microbicidal activities of 
peritoneal macrophages. Infect. Immun. 46, 448–452 (1984).
 32. Baron, E. J. & Proctor, R. A. Elicitation of peritoneal polymorphonuclear neutrophils from mice. J. Immunol. Methods 49, 305–313 
(1982).
 33. Lam, D., Harris, D. & Qin, Z. Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage 
mediator production inhibition during thioglycollate elicited peritoneal inflammation. Mediat. Inflamm. 2013, 1–9 (2013).
 34. Poli-de-Figueiredo, L. F., Garrido, A. G., Nakagawa, N. & Sannomiya, P. Experimental models of sepsis and their clinical relevance. 
Shock 30, 53–59 (2008).
 35. Hölzer, S. U. & Hensel, M. Functional dissection of translocon proteins of the Salmonella Pathogenicity Island 2-encoded type III 
secretion system. BMC Microbiol. 10, 104 (2010).
 36. Keane, C., Jerkic, M. & Laffey, J. G. Stem cell–based therapies for sepsis. Anesthesiology 127, 1017–1034 (2017).
 37. Brawn, L. C., Hayward, R. D. & Koronakis, V. Salmonella SPI1 effector SipA persists after entry and cooperates with a SPI2 effector 
to regulate phagosome maturation and intracellular replication. Cell Host Microbe 1, 63–75 (2007).
 38. Sala, E. et al. Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine. 
Gastroenterology 149, 163–176 (2015).
 39. Wu, X. et al. Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous 
progenitor differentiation in type 1 diabetic mice. Stem Cells Dev. 23, 1245–1257 (2014).
 40. Khanjani, S. et al. Efficient generation of functional hepatocyte-like cells from menstrual blood-derived stem cells. J. Tissue Eng. 
Regen. Med. 9, 124–134 (2015).
 41. Chen, L. et al. Human menstrual blood-derived stem cells ameliorate liver fibrosis in mice by targeting hepatic stellate cells via 
paracrine mediators. Stem Cells Transl. Med. 6, 272–284 (2017).




Scientific Reports |        (2020) 10:21389  | https://doi.org/10.1038/s41598-020-78423-x
www.nature.com/scientificreports/
 43. Anderson, P. et al. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from 
experimental colitis and sepsis. Gut 62, 1131–1141 (2013).
 44. Maggini, J. et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. 
PLoS ONE 5, e9252 (2010).
 45. Kim, J. & Hematti, P. Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages. Exp. 
Hematol. 37, 1445–1453 (2009).
 46. Fleming, S. D. & Campbell, P. A. Macrophages have cell surface IL-10 that regulates macrophage bactericidal activity. J. Immunol. 
156, 1143–1150 (1996).
 47. Németh, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages 
to increase their interleukin-10 production. Nat. Med. 15, 42–49 (2009).
 48. Chen, G. Y. & Nuñez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826–837 (2010).
 49. Rajaee, A., Barnett, R. & Cheadle, W. G. Pathogen- and danger-associated molecular patterns and the cytokine response in sepsis. 
Surg. Infect. (Larchmt) 19, 107–116 (2018).
 50. Zhang, Q. Z. et al. Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous 
wound healing. Stem Cells 28, 1856–1868 (2010).
 51. Grunwald, U. et al. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J. Immunol. 157, 
4119–4125 (1996).
 52. Vasandan, A. B. et al. Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE 
2 -dependent mechanism. Sci. Rep. 6, 1–17 (2016).
 53. Srikanth, C. V. & Cherayil, B. J. Intestinal innate immunity and the pathogenesis of Salmonella enteritis. Immunol. Res. 37, 61–77 
(2007).
 54. Li, Y. et al. P40phox-deficient mice exhibit impaired bacterial clearance and enhanced pro-inflammatory responses during Sal-
monella enterica serovar Typhimurium infection. Front. Immunol. 8, 1–16 (2017).
 55. Taub, N. et al. The late endosomal adaptor p14 is a macrophage host-defense factor against Salmonella infection. J. Cell Sci. 125, 
2698–2708 (2012).
 56. Mastroeni, P. et al. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental 
salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192, 237–248 (2000).
 57. Vazquez-Torres, A. et al. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287, 
1655–1658 (2000).
 58. Watanabe, H., Numata, K., Ito, T., Takagi, K. & Matsukawa, A. Innate immune response in Th1- and Th2-dominant mouse strains. 
Shock 22, 460–466 (2004).
 59. Ruiz, S. et al. Sepsis modeling in mice: ligation length is a major severity factor in cecal ligation and puncture. Intensive Care Med. 
Exp. 4, 22 (2016).
 60. Laroux, F. S., Romero, X., Wetzler, L., Engel, P. & Terhorst, C. Cutting edge: MyD88 controls phagocyte NADPH oxidase function 
and killing of gram-negative bacteria. J. Immunol. 175, 5596–5600 (2005).
 61. El Bekay, R. et al. Activation of phagocytic cell NADPH oxidase by norfloxacin: a potential mechanism to explain its bactericidal 
action. J. Leukoc. Biol. 71, 255–261 (2002).
Acknowledgements
R.M.-A. is a PhD student belonging to the Official Doctoral Programme in Biomedicine of the University of 
Granada. The authors thank Dr. Ana Santos Carro for invaluable advice and excellent technical assistance with 
confocal microscopy, Dr. Francisco O’Valle Ravassa for H&E staining and histopathological evaluation of the 
aggregate sections and Dr. Adam J.R. Gadd for revising the use of English in the manuscript.
Author contributions
R.M.-A. carried out the majority of the experiments, performed the statistical analysis of the results and prepared 
the first draft of the manuscript. S.R.-P. and M.J.R.-M. were involved in data collection and analysis as well as 
assistance in performing the experiments. E.G.O. contributed to the assembly and data analysis and the financial 
support. C.R.-R and A.C.A.-M. designed the different experiments, interpreted the results, contributed to the 
financial support and critically reviewed the manuscript. All authors read and approved the final manuscript.
Funding
This research project was supported by the Plan Estatal de Investigación Científica y Técnica y de Innovación 
2013–2016, ISCIII-Subdirección General de Evaluación y Fomento de la Investigación, Ministerio de Economía 
y Competitividad, Spain (Grant PI16/01642 and PI10/01096), European Regional Development Fund (ERDF/
FEDER funding), and the Cátedra de Investigación Antonio Chamorro–Alejandro Otero, Universidad de Gra-
nada (Grant CACH2017-1).
Competing interests 
The authors declare no competing interests.
Additional information
Supplementary Information The online version contains supplementary material available at https ://doi.
org/10.1038/s4159 8-020-78423 -x.
Correspondence and requests for materials should be addressed to C.R.-R. or A.C.A.-M.
Reprints and permissions information is available at www.nature.com/reprints.




Scientific Reports |        (2020) 10:21389  | https://doi.org/10.1038/s41598-020-78423-x
www.nature.com/scientificreports/
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons licence, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
© The Author(s) 2020
